Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 28, 2006; 12(8): 1265-1269
Published online Feb 28, 2006. doi: 10.3748/wjg.v12.i8.1265
Published online Feb 28, 2006. doi: 10.3748/wjg.v12.i8.1265
Table 5 Laboratory abnormalities
| Triple therapy group | Dual therapy group | ||
| Decrease in WBC (<2 000 μL) | 5 | 5 | NS |
| (<1 500 μL) | 1 | 0 | NS |
| Decrease in hemoglobin (> 10 g/dL) | 13 | 14 | NS |
| (>8.5 g/dL) | 3 | 4 | NS |
| Decrease in platelet count (<50 000 μL) | 1 | 3 | NS |
| IFN dose reduction | 9 | 10 | NS |
| Ribavirin dose reduction | 15 | 17 | NS |
- Citation: Suzuki H, Takagi H, Sohara N, Kanda D, Kakizaki S, Sato K, Mori M. Triple therapy of interferon and ribavirin with zinc supplementation for patients with chronic hepatitis C: A randomized controlled clinical trial. World J Gastroenterol 2006; 12(8): 1265-1269
- URL: https://www.wjgnet.com/1007-9327/full/v12/i8/1265.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i8.1265